Latest News from: Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Filters close
Newswise: Characterization of mutational “coldspots” in the cancer genome
Release date: 10-Apr-2024 8:05 AM EDT
Characterization of mutational “coldspots” in the cancer genome
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Researchers at IRB Barcelona report mutation rate variation across the human genome. Regions with low mutation rates correlate with hypomethylation (low methylation levels), a way cells control which genes are turned on or off. Published in Nucleic Acids Research, the study sheds light on the accumulation of somatic mutations through cancer and ageing, providing valuable knowledge.

UNREVIEWED

18-Mar-2024 7:05 PM EDT
Researchers from IRB Barcelona and Sant Joan de Déu unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

A team from IRB Barcelona and Sant Joan de Déu Hospital · IRSJD has studied the cases of four children who have experienced two cancers during childhood and has addressed the origin of the second tumour.

Released: 6-Mar-2024 8:05 AM EST
Launch of a pioneering translational research programme in Europe
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

- The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients. - TRIP will focus on emerging fields such as immuno-oncology, inflammation, and cellular senescence.

Released: 30-Jan-2024 6:05 AM EST
New drug reveals a key mechanism to overcome resistance to protein degraders
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Protein degraders offer a novel approach to targeting undruggable diseases by hijacking the cell's degradation machinery.

Newswise: Chemotherapy becomes more efficient when senescent cells are eliminated by immunotherapy
23-Jan-2024 9:30 AM EST
Chemotherapy becomes more efficient when senescent cells are eliminated by immunotherapy
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Researchers from IRB Barcelona describe a mechanism by which senescent cells generated by chemotherapy survive inside tumours.

Newswise: Bladder tumours reduced by 90% using nanorobots
Released: 15-Jan-2024 7:05 AM EST
Bladder tumours reduced by 90% using nanorobots
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface.

   
Newswise: Candida evolution disclosed: new insights into fungal infections
12-Jan-2024 5:00 AM EST
Candida evolution disclosed: new insights into fungal infections
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Identification of genes under recent selection provides insights into the molecular mechanisms of human-related adaptation in Candida pathogens.

Newswise: Unravelling individual differences in DNA mutation risks
9-Jan-2024 5:00 AM EST
Unravelling individual differences in DNA mutation risks
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Researchers at IRB Barcelona discover unexpected patterns in mutation risks across individuals, uncovering 13 distinct genomic patterns.

Newswise: Iron accumulation: a new insight into fibrotic diseases
13-Dec-2023 6:00 PM EST
Iron accumulation: a new insight into fibrotic diseases
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

• Researchers at IRB Barcelona reveal the pivotal role of iron accumulation in the development of fibrotic diseases and propose that iron detection via MRI can serve to diagnose fibrosis. • Fibrotic diseases account for 45% of all mortality in developed countries. • Published in Nature Metabolism, the study points to new therapeutic opportunities that target iron.

Newswise: Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
4-Dec-2023 8:00 AM EST
Hard to drug: Protein droplets reveal new ways to inhibit transcription factors in an aggressive form of prostate cancer
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Many of the most potent human oncoproteins belong to a class of proteins called transcription factors, but designing small molecule drugs that target transcription factors is a major challenge.

Newswise: A change in rigidity switches the function of protein condensates involved in sensing touch
Released: 22-Oct-2023 4:05 PM EDT
A change in rigidity switches the function of protein condensates involved in sensing touch
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

A team of researchers describes in Nature Cell Biology the mechanism by which the MEC-2 protein condensates of the touch receptor neurons transition from fluid to solid-like states, switching their role in the transmission of mechanical forces. These findings pave the way for developing innovative therapies and treatments.

Newswise: Palex and Inbiomotion introduce pioneering test to aid
oncologists in predicting recurrence and survival rates in breast
cancer patients
Released: 29-Sep-2023 8:05 AM EDT
Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Spain is the first country in the world to have this technology • Results showing the clinical utility of the test were published in Lancet Oncology and the Journal of National Cancer Institute • The test is now available to oncologists and pathologists and will benefit an estimated 24,000 patients each year in Spain

Newswise: Chromosomal instability in cancer cells causes DNA damage and promotes invasiveness
Released: 26-Sep-2023 4:00 AM EDT
Chromosomal instability in cancer cells causes DNA damage and promotes invasiveness
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Chromosomal instability is a phenomenon characterised by rapid changes in the number and structure of chromosomes during cell division. It is very common in solid tumours and it is linked to the aggressive spread of cancer, that is to say, metastasis.

Newswise: A medication used for heart conditions improves the efficacy of current treatments for melanoma
9-Aug-2023 10:00 AM EDT
A medication used for heart conditions improves the efficacy of current treatments for melanoma
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.

Released: 9-Aug-2022 1:05 PM EDT
Gene editing via CRISPR/Cas9 can lead to cell toxicity and genome instability
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Researchers at IRB Barcelona identify critical spots on the genome where gene editing could cause an unwanted response, and they provide recommendations for safer approaches.

Released: 5-Jul-2022 2:15 PM EDT
Hereditary factors that increase the likelihood of cancer mutations detailed in new study
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Mutations occur in various tissues and organs of an individual. Somatic mutations occur in cells that will not give rise to offspring and are therefore not passed on to subsequent generations.


Showing results 1 – 16 of 16


close
0.12499